Robert W. Shafer
Publication Details
-
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
AIDS. 2007; (2): 215-23
Monitoring regional levels of transmitted HIV-1 resistance informs treatment guidelines and provides feedback on the success of HIV-1 prevention efforts. Surveillance programs for estimating the frequency of transmitted resistance are being developed in both industrialized and resource-poor countries. However, such programs will not produce comparable estimates unless a standardized list of drug-resistance mutations is used to define transmitted resistance.
Help